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To evaluate the role of chest CT in the initial staging of testicular seminomatous germ cell tumours. All patients referred to
Addenbrooke’s Hospital with testicular seminoma from 1 January 2000 to 31 December 2005 were included and case notes
retrospectively reviewed. One hundred and eighty-two patients with testicular seminoma were identified, with a median age of 37
years (range 19–74). Most patients had stage I disease (86%). Twenty-four patients had abnormal abdominal CT findings. One
hundred and fifty-eight had normal abdominal CT findings but, on initial staging, chest CT reported abnormalities in 13 patients,
which, on further follow-up CT were deemed to be irrelevant to the diagnosis of seminoma. There was a further patient with a
normal CT abdomen in whom chest CT detected obvious metastatic disease, which was seen on chest x-ray. Overall 18 cases
required additional investigations and follow-up for abnormalities subsequently found to be benign. There was a false-positive rate of
10% for initial staging with chest CT. This is the largest reported series of staging CT chest in testicular seminoma. In all patients with
normal abdominal CT, normal chest x-ray and abnormal chest CT, subsequent follow-up investigations demonstrated that the lung
lesions were incidental findings.
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Testicular cancer is relatively uncommon accounting for less than
1% of all male cancers, but its incidence is increasing (Roth and
Nichols, 1992). It affects mainly young men and carries an
excellent prognosis when treated appropriately (International
Germ Cell Collaborative Group, 1997). Initial staging is heavily
dependent on radiological imaging and this plays a crucial
role in subsequent treatment decisions (MacVicar, 1993).
There is evidence that seminoma tends to metastasise in a serial
fashion through the lymphatic system with contiguous disease
spread from abdomen to mediastinum and then neck (Wood
et al, 1996).
The relative use of computed tomography (CT) chest and chest
x-rays and the optimum schedule for reassessment for stage I
testicular tumours is controversial with practice varying consider-
ably between centres (Nathan and Rustin, 2003). It has been our
practice to obtain a CT chest in all patients as part of their initial
staging work-up as recommended by Royal College of Radiology
(COIN) guidelines (2000). CT chest is unquestionably more
sensitive than plain chest x-ray at detecting small pulmonary
metastases (Williams et al, 1987; White et al, 1999), but this has to
be balanced against the risk of detecting benign abnormalities not
seen on chest x-ray. In addition, there is the small risk of the
increased radiation exposure.
This study evaluates the role of initial CT chest in the staging
work-up of seminomatous germ cell tumours.
PATIENTS AND METHODS
A retrospective analysis of 182 consecutive patients referred
from the date of their orchidectomy from first January 2000 to
thirty-first December 2005 with a histologically confirmed
diagnosis of seminoma was performed. Data recorded from
this 6-year-period included all initial staging investigations and
subsequent radiological imaging, recording the clinical course
and follow-up results.
All available imaging was reviewed again by a radiologist
to ensure no thoracic lesions were missed at initial diagnosis.
If a chest x-ray was also performed this was recorded as well. The
Royal Marsden Hospital Staging Classification was used to stage
the tumours (Horwich, 1991). The clinical notes were used to
record clinical course and outcome. Our institutional practice was
to discuss all new referrals at the Testis Multi-Disciplinary Team
meeting (MDT) and the relevant pathology and radiology were
reviewed before reaching a treatment decision. If an abnormality
was found on chest CT and was felt to be of questionable
significance, then a repeat chest CT was performed after a 6–12
week interval. The results would then be discussed again at
the MDT and a decision made about further investigations or
treatments.
Staging examinations of the chest, abdomen and pelvis were
performed using CT at the local regional hospital or at the tertiary
referral centre. Images were acquired following the administration
of intravenous contrast medium, with the thoracic and abdominal
images obtained at 25 and 70s after the bolus injection,
respectively. Two doses of oral contrast medium taken 1h apart
were also routinely administered. Follow-up examinations were Received 30 October 2006; accepted 25 January 2007
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sperformed at the tertiary referral centre following administration
of oral contrast medium; the need to use intravenous contrast
medium at this stage was left to the discretion of the reporting
radiologist. Thoracic examinations were performed from lung
apices to costophrenic recesses using contiguous 5–10mm (or
thinner) slices, depending upon the centre where the study was
performed. Abdominal and pelvic examinations were performed
using contiguous 10mm (or thinner) slices from the dome of the
diaphragm to the pubic symphysis. Examinations from regional
hospitals were displayed as hard copy films with images of the
thorax printed at mediastinal and lung window settings as this
study preceded digital transmission from all hospitals. Examina-
tions from the tertiary referral centre were available for review on a
proprietary workstation.
RESULTS
The median age was 37 years with a range of 19–74 years. The
majority (86%) were stage I disease (Table 1). A further 4.5% were
Stage IIA, 2% stage IIB, 6% stage IIC, and 1.5% stage III and above.
Computed tomography chest was reported to reveal an abnorm-
ality in 12% (21) of the 182 cases. Chest x-ray was abnormal in four
of these cases.
Stage I disease – normal CT abdomen
Of the 157 patients with Stage I disease, CT of the chest
was reported as abnormal in 13 (8%), one of whom had an
abnormal chest x-ray (Table 2). Of these 13 cases, nine
showed parenchymal lung lesions of uncertain significance,
typically lung nodules of o5mm in size (Figure 1A and B).
In two patients CT demonstrated enlarged intrathoracic
lymph nodes of just over 1cm (Figure 2). One patient had an
abnormal chest x-ray and CT chest showed a 2cm pleurally
based lesion (unchanged after treatment, presumed granulo-
matous disease). And one case was found to have an anterior
mediastinal mass that was surgically removed and confirmed
to be a thymoma. Apart from this thymoma case, none of
the follow-up CT chest examinations showed any change in the
lung findings and these lung lesions were all deemed to be
incidental. Thus in stage I disease, where abdominal CT and
chest x-ray are normal, staging CT chest gives a false-positive rate
of 100%.
Stage II disease – abnormal CT abdomen
All 22 patients in the stage II group had abnormal abdominal CT
findings. In five patients (23%) the chest CT findings were
abnormal. In none of the five patients was the abnormality on
chest CT found to be because of a malignant cause (Table 3). In
the eight patients with stage IIA disease, two had abnormal chest
CT findings. One showed a 2cm superior mediastinal mass and
the other case showed multiple pulmonary nodules all of o5mm
in size. These did not change after chemotherapy and were
assumed to be due to granulomatous disease. In both patients the
abdominal mass showed a complete radiological response.
There were no patients with stage IIB disease with abnormal chest
CT findings. There were three patients out of the 11 with stage IIC
Table 1 Patient demographics








Age: median, 37 years; range, 19–74 years.

















IIA 2 2 Type 2¼50%
Type 1¼50% 100%
IIC 3 3 Type 1¼100% 100%
IIIB 1 1 Type 2¼100% Not applicable
IIIO 0 1 Type 2¼100% Not applicable
IVL3 1 1 Type 1¼100% Not applicable
aTypes of lung lesions are: 1¼parenchymal lung mets, 2¼intrathoracic nodal mets,
3¼other lesions F/U¼follow-up.
Figure 1 (A) lung nodule posteriorly left upper lobe; presumed
granuloma, unchanged on sequential chest CT. (B) lung nodules anteriorly
right middle lobe and laterally right lower lobe; presumed granuloma,
unchanged on sequential chest CT.
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sdisease with abnormal CT chest. One had an abnormal chest x-ray
which showed a right midzone subsegmental collapse. All three
cases had abnormal CT chest, with parenchymal lung nodules
of o5mm in size. On follow-up CT these did not change,
despite good responses of the abdominal disease to chemotherapy
in all patients.
Stage III and IV disease
Stage III disease, by definition, is associated with supradiaphrag-
matic lymphadenopathy. Two such patients were identified. One
patient had bilateral 5cm hilar lymphadenopathy associated with
bulky para-aortic lymphadenopathy. These hilar nodes regressed
on chemotherapy. The second patient had an abnormal chest
x-ray with left basal atelectasis. Computed tomography chest
showed a large anterior mediastinal nodal mass and a left internal
mammary lymph node (Figure 3). The CT abdomen was normal.
The mediastinal nodal mass regressed completely with chemother-
apy. There was one stage IV case with a normal chest x-ray.
Computed tomography of the abdomen revealed a 6 7cm aorto-
caval nodal mass, enlarged common iliac lymph nodes and on
chest CT, small nodules over both hemidiaphragms and in the
right middle lobe.
The false-positive rate for CT chest in the initial staging of
seminomatous germ cell tumours of the testis is 10%. The false-
negative rate is 0%. The positive predictive value of CT chest is
0.14, and the negative predictive value is 1. The sensitivity is 1 and
the specificity is 0.89. Overall lung metastases were detected in
1.6% of cases.
DISCUSSION
Seminomatous germ cell tumours are primarily a disease of young
men and with appropriate treatment they have an excellent
prognosis with a cure rate of 95%. These patients are likely to live
for decades after treatment and the risk of radiation-induced
second solid malignancies that manifest 12–25 years post-
exposure is a real threat. This has largely been related to
therapeutic irradiation (Travis et al, 1997; Zagars et al, 2004).
Under the ionising radiation (medical exposure) regulations
(2001), there is a legal requirement to keep radiation dose as low
as reasonably achievable, and the radiation exposure from a CT
chest is approximately equivalent to 400 chest x-rays, equivalent to
a risk of radiation-induced second malignancies of 1 in 2000 (RCR,
2003). If chemotherapy is increasingly used (Oliver et al, 2005);
diagnostic imaging will assume greater importance. Chest CT has
been established as the imaging modality of choice for staging
patients with teratoma of the testis (Bradey et al, 1987). Once the
histological diagnosis of seminoma is confirmed, formal radi-
ological staging is required.
There is good evidence for contiguous lymphatic spread in
seminoma (Wood et al, 1996). In a series of 31 patients with
supradiaphragmatic metastases of which 11 were seminoma, they
confirmed the contiguous nature of disease spread from abdomen
to chest and neck in seminoma. Supradiaphragmatic disease tends
to be contiguous spread from the retroperitoneum through the
retrocrural groups and into the posterior mediastinum where the
paraoesaphageal and subcarinal lymph nodes are most frequently
involved. Pulmonary metastases without abdominopelvic lympha-
denopathy are rare. This would support the theory that seminoma
tends to metastasise in a relatively predictable fashion through the
lymphatic system and a normal CT abdomen and pelvis could
exclude the need for a CT chest, if chest x-ray is normal.
A number of studies have been published that address the issue
of thoracic imaging in non-seminomatous germ cell tumours
(NSGCT) specifically. In one series (Harvey et al, 2002) with 168
patients on surveillance, eight developed thoracic metastases, all of
which were visible on chest x-ray. Another study (Fernandez et al,
1994) highlighted the difference in sensitivity between chest x-ray
and CT, comparing CT chest at initial diagnosis to chest x-ray in
117 patients with NSGCT. Twenty-one patients had thoracic
metastases on CT, of which five were missed on plain chest
x-ray. This could have potentially altered treatment in two of these
five patients. The role of CT and chest x-ray in 207 germ cell
tumour patients has been evaluated (White et al, 1999) and
found intrathoracic metastases in only 1% of seminoma patients.
However, they still advised CT chest in the initial staging. The
Figure 2 Precarinal lymph nodes 1cm in size, unchanged on sequential
chest CT.
Table 3 Analysis from CT abdomen results





CXR Normal¼22 5 1
on CT IIB¼3
(n¼24) IIC¼11




I¼157 CXR Normal¼156 12 0
on CT
(n¼158)
CXR Abn ¼11 0
IIIO¼1 CXR Abn¼11 1
Figure 3 1.2cm left internal mammary lymph node; unchanged on post
chemotherapy chest CT, cause uncertain but it would be an unusual site for
seminoma metastases.
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sNorth American literature advocates chest x-ray alone for
both staging and follow-up surveillance of seminoma where a CT
abdomen is negative (Steinfield and Macher, 1990; Moul, 1995; See
and Hoxie, 1993).
Computed tomography abdomen is used in the initial staging of
seminomatous germ cell tumours of the testis and usually CT chest
is performed at the same time. Computed tomography is now
often done before histology results are available so it is not
practical to omit staging chest CT. There has also been a major
evolution in chest CT, now that many centres have modern
multidetector CT. Using high resolution (HRCT) algorithms, CT
chest can be reconstructed for optimal demonstration of lung
parenchyma. The number of thin sections has increased substan-
tially and the number of small incidental findings has correspond-
ingly increased (Hayward, 2003). Some of these incidental findings
represent pre-existing sarcoid, which is a well-recognised trap
when staging young people (Remy-Jardin et al, 1991).
We question whether the CT chest should influence manage-
ment and delay treatment if the abdominal CT is normal, as there
is a significant false-positive rate of 10% for chest CT in our single
institution series. The issue of false-positive CT chest is a serious
one, as the delay between the initial CT and the subsequent follow-
up CT in 6–12 weeks can be psychologically distressing for both
patients and their families. For those cases that could be stage I,
treatment cannot start until the lung abnormalities have been
clearly defined as incidental or malignant, as the treatment
regimens are so different. We found that for stage I disease,
100% of chest CT abnormalities were determined to be incidental
on subsequent follow-up. There was one case with an anterior
mediastinal mass which was correctly identified as a thymic mass
and surgically removed. No abnormality was related to the
diagnosis of seminoma.
We conclude that for patients with normal abdominal CT
findings and thereby presumed low stage tumours, any abnorm-
ality in the chest CT should not necessarily influence management
or delay treatment. Computed tomography chest has unacceptable
false-positive rates and should not precipitate further additional
invasive investigations. This would avoid delay in diagnosis and
treatment caused by the unnecessary investigation of incidental
lung nodules.
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